Bill Hawkins predicts “mild pain” after the FDA’s 510(k) overhaul |

Bill Hawkins predicts “mild pain” after the FDA’s 510(k) overhaul

Medtronic’s Hawkins: 510(k) changes to be ‘neutral to slightly negative’ (MedCityNews)

Outgoing Medtronic (NYSE:MDT) Chief Executive Bill Hawkins is predicting only mild pain when the federal government unveils changes to the 510(k) rules governing approval for most medical devices.

Leave a Reply

Your email address will not be published. Required fields are marked *

FREE White Paper!
7 Disruptive Trends in Orthopedics
* No Spam - we will never share your details.